Patient trust is the constraint. enclaive makes it the architecture
Every diagnostic model, every multi-site study, every data space runs up against the same wall: health data is too sensitive to share and too valuable not to use. enclaive turns the wall into infrastructure — data encrypted even during computation, collaboration on results instead of records, sovereignty enforced by silicon rather than contracts. AI diagnostics without exposure, cross-institution research without raw-data pooling, compliance by design under GDPR and beyond.

Platforms, records and analytics on cloud economics — patient data sealed from every infrastructure operator, attestation instead of assurances.
The trusted-runtime layer gematik's specifications describe — for ePA-adjacent services, telemedicine and TI applications, as buildable infrastructure your architecture review can approve. ePA, eRezept and the sectoral Identity Provider already run on confidential computing — the VAU in gematik's terms.
Your product doesn't change.Your hardest sales objection does
EMR, telemedicine, imaging, health AI — deployed exactly as they are. No rewrites, no SDK.
Confidential VMs, Kubernetes and encrypting databases — patient data encrypted in use, per tenant, on whatever cloud your customer requires. [PLACEHOLDER — confirm encrypted-database catalog before naming services publicly.]
Your customer holds their own keys; only verified, untampered workloads can decrypt — everything else fails attestation and gets nothing.
What healthcare teams ask
Do we need to rewrite our systems or products?
No — workloads and product images run in confidential environments without code changes. Start with the data platform or a new service, not the KIS core.
How does this change the GDPR Art. 9 position?
Encryption that persists during processing is materially stronger than the at-rest/in-transit baseline — DPIAs get an enforcement claim instead of a promise. The legal assessment stays yours; the premise improves.
Are you gematik-approved?
Approval attaches to products, not infrastructure vendors. enclaive provides the runtime layer matching the requirement class gematik describes; your product pursues approval on top.
Can clinicians use Confidential AI on patient data?
Sealed inference removes the exposure for self-hosted models; the pseudonymization layer covers external ones. What remains is your governance decision — on a defensible technical premise.
We're a vendor — what does this change in our customers' DPIAs and DPA negotiations?
The technical premise: Art. 9 data processed with encryption in use and customer-held keys is a materially stronger position than contractual assurances over readable infrastructure. Your customer's DPO gets an enforcement claim to assess instead of a promise to trust.
Where does the data physically sit?
Wherever your requirements point — German/EU providers, your datacenter, or both. The operator is excluded by architecture either way.
Bring the platform, the study, or the product
Tell us which one — we'll show you the pattern already carrying it, in production, in Germany.
.png)
